|
gptkbp:instance_of
|
gptkb:Skin
|
|
gptkbp:adverse_reaction_reporting
|
report to healthcare provider
|
|
gptkbp:atccode
|
R03 AC02
|
|
gptkbp:brand
|
gptkb:Ventolin
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:class
|
gptkb:Spider-Man
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:clinical_use
|
rescue inhaler
|
|
gptkbp:community_service
|
approved for children 4 years and older
|
|
gptkbp:contraindication
|
hypersensitivity to albuterol
|
|
gptkbp:dosage_form
|
metered-dose inhaler
|
|
gptkbp:drug_interactions
|
MAO inhibitors
diuretics
beta-blockers
|
|
gptkbp:duration
|
4 to 6 hours
|
|
gptkbp:effective_date
|
gptkb:1981
|
|
gptkbp:financial_support
|
available
|
|
gptkbp:form
|
aerosol
|
|
gptkbp:formulation
|
gptkb:Spider-Man
|
|
gptkbp:healthcare
|
yes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ventolin HFA
|
|
gptkbp:indication
|
gptkb:asthma
gptkb:chronic_obstructive_pulmonary_disease_(COPD)
|
|
gptkbp:ingredients
|
albuterol
|
|
gptkbp:inhalation_technique
|
correct technique is essential
|
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:Canada
gptkb:UK
gptkb:United_States
|
|
gptkbp:mechanism_of_action
|
beta-2 adrenergic agonist
|
|
gptkbp:ndc
|
00006-0060
|
|
gptkbp:packaging
|
pressurized canister
|
|
gptkbp:patient_education
|
instruct on use
|
|
gptkbp:premiered_on
|
within minutes
|
|
gptkbp:previous_name
|
gptkb:albuterol_sulfate
|
|
gptkbp:price
|
varies by pharmacy
|
|
gptkbp:refill_information
|
may require refills
|
|
gptkbp:requires
|
gptkb:true
|
|
gptkbp:route_of_administration
|
inhalation
|
|
gptkbp:safety
|
consult prescribing information
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
headache
nervousness
tremors
palpitations
throat irritation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:strength
|
90 mcg per actuation
|
|
gptkbp:type_of_care
|
important for effectiveness
|
|
gptkbp:type_of_insurance
|
may be covered
|
|
gptkbp:bfsParent
|
gptkb:Ventolin
|
|
gptkbp:bfsLayer
|
7
|